4-hydroxymethyl-3,5-dimethyl-1H-pyrazole | 89600-69-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-hydroxymethyl-3,5-dimethyl-1H-pyrazole
• 英文别名: (3,5-dimethyl-1H-pyrazol-4-yl)-methanol；3,5-dimethyl-4-hydroxymethylpyrazole；(3,5-dimethyl-1H-pyrazol-4-yl)methanol
• CAS: 89600-69-1
• 化学式: C₆H₁₀N₂O
• mdl: MFCD00159591
• 分子量: 126.158
• InChiKey: BCHDDNSNRITNKW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  48.9
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-hydroxymethyl-3,5-dimethyl-1H-pyrazole 在 氯化亚砜 作用下， 反应 1.0h， 生成 4-(Chloromethyl)-3,5-dimethyl-1h-pyrazole Hydrochloride
  参考文献：
  名称：

  Synthesis and structural characterization of (CH2)n-bridged indenyl-pyrazoles and their cyclopentadienyl nickel(II) complexes

  摘要：

  A new class of (CH2)(n)-bridged indenyl-pyrazoles [4-{Ind-(CH2)(n)}-RR'PzH] (Ind = 1H-inden-3-yl, n = 1-3, RR'Pz = 3,5-disubstituted pyrazolato) were synthesized. Reactions of the indenyl-functionalized pyrazoles with nickelocene in refluxing toluene afforded trimetallic and dimetallic cyclopentadienyl nickel(II) complexes, i.e., [CpNi{4-(Ind-(CH2)(n))-RR'Pz}(2)](2)Ni and [CpNi{4-(Ind-(CH2)(n))-RR'Pz}](2), depending on the steric hindrance from the 3,5-disubstituents on the pyrazolato rings. In the CpNi(II) complexes, pyrazolato ligands exhibit mu-eta(1): eta(1) coordination to the metal centers and the indenyl moieties demonstrate no interaction with the metals. All the indenyl-pyrazoles and their complexes were characterized by spectroscopic and analytical methods including X-ray crystallographic study. (C) 2008 Elsevier B. V. All rights reserved.

  DOI：

  10.1016/j.jorganchem.2008.10.021
• 作为产物：
  描述：

  3,5-二甲基-1H-4-吡唑羧酸乙酯 在 lithium aluminium tetrahydride 、 乙醚 作用下， 生成 4-hydroxymethyl-3,5-dimethyl-1H-pyrazole
  参考文献：
  名称：

  FORMALDEHYDE CONDENSATION IN THE PYRAZOLE SERIES

  摘要：

  DOI：

  10.1021/jo01152a026

文献信息

• [EN] PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DE PROTÉINE TYROSINE PHOSPHATASE ET LEURS PROCÉDÉS D'UTILISATION
  申请人：CALICO LIFE SCIENCES LLC

  公开号：WO2020186199A1

  公开（公告）日：2020-09-17

  Provided herein are compounds, compositions, and methods useful for inhibiting protein tyrosine phosphatase, e.g., protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases, disorders and conditions favorably responsive to PTPN 1 or PTPN2 inhibitor treatment, e.g., a cancer or a metabolic disease.

  本文提供了用于抑制蛋白酪氨酸磷酸酶的化合物、组合物和方法，例如蛋白酪氨酸磷酸酶非受体型2（PTPN2）和/或蛋白酪氨酸磷酸酶非受体型1（PTPN1），以及用于治疗对PTPN1或PTPN2抑制剂治疗有良好反应的相关疾病、紊乱和状况的方法，例如癌症或代谢性疾病。
• Chemokine receptor binding compounds
  申请人：Zhou Yuanxi

  公开号：US20070066624A1

  公开（公告）日：2007-03-22

  The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR4 or CCR5. In one aspect, these compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).

  本发明涉及化学因子受体结合化合物、药物组合物及其使用。更具体地，本发明涉及化学因子受体活性调节剂，优选地为CCR4或CCR5的调节剂。在一个方面，这些化合物表现出对人类免疫缺陷病毒（HIV）感染靶细胞的保护效应。
• Flexible hydrophilic articles having a durable antimicrobial effect
  申请人：Reckitt & Colman Inc.

  公开号：EP0869216A1

  公开（公告）日：1998-10-07

  Flexible wiping articles in particular sponges, as well as woven or non-woven wipes, and the like feature a long term antimicrobial benefit even subsequent to continued use. According to one aspect of the invention, the articles comprise a biocidal composition having a low aqueous solubility. According to a second aspect of the invention, the articles comprise a carrier of low aqueous solubility having dispersed within a biocidal composition. Methods for preparing the articles, and processes for their use are also disclosed.

  柔性擦拭用品，特别是海绵、编织或无纺擦拭布等，即使在持续使用后也具有长期抗菌效果。根据本发明的一个方面，这些物品包含一种水溶性低的杀菌组合物。根据本发明的第二个方面，物品包括分散在杀菌组合物中的低水溶性载体。 本发明还公开了制备这些物品的方法及其使用过程。
• Protein tyrosine phosphatase inhibitors and methods of use thereof
  申请人：Calico Life Sciences LLC

  公开号：US10851073B2

  公开（公告）日：2020-12-01

  Provided herein are compounds, compositions, and methods useful for inhibiting protein tyrosine phosphatase, e.g., protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases, disorders and conditions favorably responsive to PTPN1 or PTPN2 inhibitor treatment, e.g., a cancer or a metabolic disease.

  本文提供的化合物、组合物和方法可用于抑制蛋白酪氨酸磷酸酶，例如蛋白酪氨酸磷酸酶非受体2型（PTPN2）和/或蛋白酪氨酸磷酸酶非受体1型（PTPN1），以及治疗对PTPN1或PTPN2抑制剂治疗有良好反应的相关疾病、失调和病症，例如癌症或代谢性疾病。
• Topical compositions of flunisolide and methods of treatment
  申请人：Lupin Limited

  公开号：US10953021B2

  公开（公告）日：2021-03-23

  Provided herein are compositions and methods for treating or preventing a skin disease or skin condition on the skin of a subject by administering a topical flunisolide composition comprising a therapeutically effective amount of flunisolide and a solubilizing agent that solubilizes the flunisolide.

  本文提供了用于治疗或预防受试者皮肤上的皮肤病或皮肤状况的组合物和方法，其方法是施用局部氟尼缩松组合物，该组合物包含治疗有效量的氟尼缩松和可溶解氟尼缩松的增溶剂。